STAB — Statera Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $5.97m
- $1.49m
Brief: Cleveland Biolabs Q4 Loss Per Share $0.04 Excluding Items
Brief: Cleveland Biolabs Inc QTRLY Loss Per Share $0.10
Brief: Cleveland Biolabs Entered Agreement With Investor For Providing GPI With Capital
Brief: Cleveland Biolabs Quarterly Loss Per Share $0.08
Brief: Cleveland Biolabs, On Aug 6, Entered License Agreement With Genome Protection
Brief: Cleveland Biolabs Reports Quarterly Loss Per Share Of $0.11
Brief: Cleveland Biolabs Says Received Formal Notification From EMA
Brief: Cleveland Biolabs Reports Qtrly Loss Per Share $0.10
N.Korea threats spur U.S. search for new radiation therapies
Brief: Cleveland BioLabs reports Q3 net loss per share, excluding minority interests, $0.11
Brief: Cleveland BioLabs Q2 loss per share $0.50
Brief: Cleveland Biolabs announces commencement of in Vivo Biocomparability study
Brief: Cleveland Biolabs announces European Medicines Agency positive opinion regarding entolimod pediatric investigation plan
Brief: Cleveland Biolabs reports Q4 loss per share $0.11
Brief: Cleveland Biolabs Q3 revenue $1.1 million versus $500,000
Brief: Cleveland BioLabs announces a $1.1 mln cost realignment with Department of Defense
Brief: Cleveland Biolabs quarterly loss per share $0.17
Brief: Cleveland BioLabs provides update on pre-EUA review of Entolimod as radiation countermeasure
Brief: Cleveland Biolabs files shelf offering of up to 6.72 mln shares - SEC filing